M. Muzael et al. / Chemistry and Physics of Lipids 163 (2010) 678–684
683
in dry THF (15 ml) was added. The mixture was stirred for 3 h
3.14. (2R,3R,Z)-2-Docosyl-3-hydroxytetracont-21-enoic acid
(13)
when TLC showed no starting material was left, then the reac-
tion was quenched with sat. aq. NH4Cl (10 ml) and the product
was extracted with petrol:ethyl acetate (20:1) (3 × 20 ml). The
combined organic layers were dried over MgSO4, filtered and
the solvent was evaporated. The product was purified by chro-
matography over silica gel, eluting with petrol/ethyl acetate
(40:1) to give methyl (2R,3R,Z)-3-(tert-butyldimethylsilyloxy)-2-
Lithium hydroxide monohydrate (0.3 g, 5.24 mmol) was added
to a stirred solution of methyl ester 12 (0.32 g, 0.3 mmol) in THF
(10 ml), methanol (1 ml) and water (1.5 ml) at r.t. The mixture was
stirred at 40 ◦C for 18 h, when TLC showed no starting material was
left. The reaction mixture was cooled down to room temperature
and diluted with petrol/ethyl acetate (5:2, 10 ml) and acidified to
pH = 1 with 5% HCl. The product was extracted with petrol/ethyl
acetate (5:2) (3 × 10 ml), and the combined organic layers were
dried over MgSO4 and evaporated to give a crude product which
was purified by column chromatography eluting with petrol:ethyl
acetate (7:2) to give (2R,3R,Z)-2-docosyl-3-hydroxytetracont-21-
enoic acid (0.26 g, 81%) 13 as a white solid, m.p. 65–66 ◦C,
[␣]D21+3.43 (c 0.97, CHCl3) (Found [M+Na]+: 937.91, C62H122NaO3
requires: 937.93 (MALDI)) which showed ıH: 5.34–5.25 (2H, m),
3.70 (1H, dt, J 8.2, 4.95 Hz), 2.43 (1H, td, J 8.8, 5.35 Hz), 1.97 (4H,
q, J 6.65 Hz), 1.64–1.48 (16H, m), 1.21 (92H, br.s), 0.85 (6H, t J
6.6 Hz); ıC: 175.14, 129.90, 72.17, 50.52, 35.56, 31.92, 29.77, 29.70,
29.66, 29.57, 29.48, 29.41, 29.35, 29.31, 27.31, 27.21, 25.71, 22.68,
14.10; ꢀmax: 3530, 2915, 2848, 2360, 1684, 1468, 1378, 1208, 965,
24
docosyltetracont-21-enoate 10 (0.255 g, 62%), [␣]D −2.45 (c 1.18,
CHCl3) (Found [M+Na]+: 1066.0319. C69H138O3Si Na requires:
1066.0307); this showed ıH: 5.35 (2H, dt, J 11.65, 5.65 Hz), 3.91
(1H, br.td, J 7, 4.4 Hz), 3.66 (3H, s), 2.53 (1H, ddd, J 11.05, 7.25,
3.8 Hz), 2.02 (4H, br.q, J 7 Hz), 1.6–1.2 (106H, br. m), 0.89 (6H, t, J
6.6 Hz), 0.87 (9H, s), 0.05 (3H, s), 0.02 (3H, s); ıC 175.14, 129.89,
73.22, 51.57, 51.21, 33.67, 31.92, 29.83, 29.77, 29.70, 29.61, 29.58,
29.56, 29.44, 29.36, 29.31, 27.83, 27.50, 27.21, 25.75, 23.68, 22.69,
17.97, 14.11, −4.37, −4.93; ꢀmax: 2923, 2852, 1741, 1468, 1437,
1361, 1179, 1120, 836, 775, 720, 695 cm−1
.
3.12. Methyl (2R,3R,E/Z)-3-(tert-butyldimethylsilyloxy)
-2-docosyltetracont-21-enoate (11)
717 cm−1
.
The same procedure was followed as above in order
to couple aldehyde (0.19 g, 2.44 mmol) and 5-(nonadecane-1-
sulfonyl)-1-phenyl-1H-tetrazole (0.17 g, 3.66 mmol) using lithium
bis(trimethylsilyl)amide (0.5 ml, 5.38 mmol, 0.5 ml), which was
added at −10 ◦C. The product was purified by column chro-
matography eluting with petrol/ethyl acetate (40:1), to give the
title compounds 11 (0.18 g, 70%) (Found [M+Na]+: 1066.0248.
C69H138O3SiNa requires: 1066.0308). This showed ıH: (major iso-
mer) 5.4–5.38 (2H, m), 3.86 (1H, br.dt, J 6.65, 4.7 Hz), 3.61 (3H,
s), 2.48 (1H, ddd, J 11, 7.25, 3.75 Hz), 1.93–1.90 (4H, br.q, J 6 Hz),
1.5–1.15 (104H, m), 0.84 (6H, t, J 7 Hz), 0.82 (9H, s), 0.00 (3H, s),
−0.025 (3H, s); (minor isomer) 5.36–5.34 (2H, m), 1.97 (4H, br.q,
J 6.65 Hz) (the remaining signals obscured by the major isomer);
ıC (both isomers): 175.14, 130.36 (trans isomer), 129.89 (cis iso-
mer), 73.22, 51.57, 51.2, 33.68, 32.6, 31.92, 29.83, 29.78, 29.7, 29.66,
29.6, 29.58, 29.57, 29.54, 29.53, 29.44, 29.36, 29.32, 29.2, 27.82, 27.5,
27.2, 25.75, 23.69, 22.68, 22.6, 17.97, 14.1, −4.38, −4.94; ꢀmax: 2922,
2851, 2360, 1741, 1464, 1361, 1252, 1193, 1165, 1070, 1005, 965,
Acknowledgement
We thank the Government of Iraq for the award of a studentship
to M.M.
References
Al Dulayymi, J.R., Baird, M.S., Roberts, E., 2005. The synthesis of a single enantiomer
of a major alpha-mycolic acid of M. tuberculosis. Tetrahedron 61, 11939–11951.
Al Dulayymi, J.R., Baird, M.S., Roberts, E., Minnikin, D.E., 2006. The synthesis of single
enantiomers of meromycolic acids from mycobacterial wax esters. Tetrahedron
62, 11867–11880.
Al Dulayymi, J.R., Baird, M.S., Roberts, E., Deysel, M., Verschoor, J., 2007. The first syn-
thesis of single enantiomers of the major methoxymycolic acid of Mycobacterium
tuberculosis. Tetrahedron 63, 2571–2592.
Asselineau, C., Asselineau, J., 1966. Stereochimie de l’acide corynomycolique. Bull.
Soc. Chim. Fr., 1992–1999.
Asselineau, C., Asselineau, J., Lanéelle, G., Lanéelle, M.-A., 2002. The biosynthesis of
mycolic acids by Mycobacteria: current and alternative hypotheses. Prog. Lipid
Res. 41, 501–523.
835, 774, 719 cm−1
.
Baird, M.S., Koza, G., 2007. The first synthesis of single enantiomers of ketomycolic
acids. Tetrahedron Lett. 48, 2165–2169.
Barry, C.E., Lee, R.E., Mdluli, K., Sampson, A.E., Schroeder, B.E., Slayden, R.A., Yuan, Y.,
1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog.
Lipid Res. 37, 143–179.
3.13. Methyl (2R,3R,Z)-2-docosyl-3-hydroxytetracont-21-enoate
(12)
Daffé, M., Lanéelle, M.-A., Valero-Guellen, P.L., 1988. Tetraenoic and pentaenoic
mycolic acids from Mycobacterium thamnopheos—structure, taxonomic and
biosynthetic implications. Eur. J. Biochem. 164, 339–344.
Etemadi, A.H., Okuda, R., Lederer, E., 1964. Sur la structure de l’acide alpha-smegma-
mycolique. Bull. Soc. Chim. Fr., 868–870.
Etemadi, A.H., 1967. Acides mycoliques: structure, biogenese et interet phvlogene-
tique. Expose annuels de biochimie medicale 28, 77–109.
Goodfellow, M., Minnikin, D.E., 1981. Identification of Mycobacterium chelonei by
thin-layer chromatographic analysis of whole-organism methanolysates. Tuber-
cle 62, 285–287.
Gray, G.R., Wong, M.Y.H., Danielson, S.J., 1983. The major mycolic acids of Mycobac-
terium smegmatis. Prog. Lip. Res. 21, 91–107.
Koza, G., Theunissen, C., Al Dulayymi, J.R., Baird, M.S., 2009. The synthesis of single
enantiomers of mycobacterial ketomycolic acids containing cis-cyclopropanes.
Tetrahedron 65, 10214–10229.
Krembel, J., Etemadi, A.H., 1966. Sur la structure d’un nouveau type d’acides mycol-
iques de Mycobacterium smegmatis. Tetrahedron 22, 1113–1119.
Kumaraswamy, G., Markondaiah, B., 2008. Proline-catalyzed stereoselective synthe-
sis of natural and unnatural nocardiolactone. Tetrahedron 64, 5861–5865.
Lacave, C., Lanéelle, M.-A., Daffé, M., Montrozier, H., Rols, M.-P., Asselineau, C., 1987.
Structural and metabolic studies of the mycolic acids of Mycobacterium fortui-
tum. Eur. J. Biochem. 163, 369–378.
Laval, F., Lanéelle, M.-A., Déon, C., Monsarrat, B., Daffé, M., 2001. Accurate molecular
mass determination of mycolic acids by MALDI-TOF mass spectrometry. Anal.
Chem. 73, 4537–4544.
(Z)-(R)-3-(tert-Butyldimethylsilanyloxy)-octatriacont-20-
enoic-2-tetracosanoic acid methyl ester (0.4 g, 4.1 mmol) was
stirred in dry THF (10 ml) in dry polyethylene vial under nitrogen
atmosphere at r.t. Pyridine (0.3 ml) and HF-pyridine (1 ml) were
added and the mixture was stirred for 18 h at 40 ◦C. The reaction
was diluted with petrol/ethyl acetate (1:1, 10 ml) and neutralized
with sat. aq. NaHCO3. The mixture was separated and the aqueous
layer was re-extracted with petrol/ethyl acetate (1:1, 2 × 20 ml).
The combined organic layers were washed with brine, dried
and the solvent was evaporated. Chromatography eluting with
petrol/ethyl acetate (10:1) gave methyl (2R,3R,Z)-2-docosyl-3-
hydroxytetracont-21-enoate 12 as a white solid (0.32 g, 87%), m.p.
44–46 ◦C, [␣]D20+4.65 (c 1.83, CHCl3) (Found [M+Na]+: 951.9458,
C63H124NaO3 requires: 951.9443), which showed ıH: 5.31–5.24
(2H, m), 3.71 (3H, s), 3.60–3.58 (1H, m), 2.38 (1H, br.td, J 9.15,
5.35 Hz), 1.94 (4H, q, J 6.6 Hz), 1.66–1.61 (1H, m), 1.56–1.48 (4H,
m), 1.42–1.2 (102H, br. m), 0.89 (6H, t, J 6.6 Hz); ıC: 176.21, 129.89,
72.31, 51.48, 50.95, 35.70, 31.92, 29.77, 29.69, 29.60, 29.57, 29.49,
29.42, 29.35, 29.32, 27.42, 27.21, 25.72, 22.67, 14.09; ꢀmax: 3516,
Lopez-Marin, L.M., Quémard, A., Lanéelle, G., Lacave, C., 1991. Ethylenic mycolic
acid biosynthesis—extension of the biosynthetic model using cell-free-extracts
2917, 2849, 1713, 1463, 1169, 719 cm−1
.